Crude Oil Rises Over 2 Consolidated Communications Shares Plummet
CFRXDelisted Stock | USD 1.18 0.08 6.35% |
Slightly above 61% of ContraFect Corp's investor base is looking to short. The analysis of current outlook of investing in ContraFect Corp suggests that many traders are alarmed regarding ContraFect Corp's prospects. ContraFect Corp's investing sentiment can be driven by a variety of factors including economic data, ContraFect Corp's earnings reports, geopolitical events, and overall market trends.
ContraFect |
U.S. stocks traded mixed midway through trading, with the Dow Jones dropping around 100 points on Tuesday. The Dow traded down 0.33 percent to 32,782.04 while the NASDAQ rose 0.19 percent to 11,488.27. The SP 500 also rose, gaining, 0.05 percent to 3,984.36.
Read at benzinga.com
ContraFect Corp Fundamental Analysis
We analyze ContraFect Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ContraFect Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ContraFect Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
ContraFect Corp is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
ContraFect Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ContraFect Corp stock to make a market-neutral strategy. Peer analysis of ContraFect Corp could also be used in its relative valuation, which is a method of valuing ContraFect Corp by comparing valuation metrics with similar companies.
Peers
ContraFect Corp Related Equities
DRMA | Dermata Therapeutics | 2.73 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
PALI | Palisade Bio | 1.65 | ||||
UNCY | Unicycive Therapeutics | 1.47 | ||||
REVB | Revelation Biosciences | 1.33 | ||||
NRBO | Neurobo Pharmaceuticals | 0.43 | ||||
ALLR | Allarity Therapeutics | 0.90 | ||||
VRAX | Virax Biolabs | 4.83 | ||||
CNSP | Cns Pharmaceuticals | 8.33 | ||||
WINT | Windtree Therapeutics | 13.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |